- Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
-
Min KW, Ku BJ, Lee JH, Kim MS, Ahn KJ, Lee MK, Kokubo S, Yoshida S, Cho HJ, Cha BS
- KMID: 2376776
- Diabetes Metab J.
- 2017 Apr;41(2):135-145.
- doi: 10.4093/dmj.2017.41.2.135
BACKGROUND: This is a subgroup analysis of Korean patients from a phase 3 clinical trial investigating the efficacy and safety of ipragliflozin in patients with type 2 diabetes mellitus inadequately... -
- CITED
-
- Close
- SHARE
-
- Close
